Asset Allocation

As of August 31, 2026.
Type % Net
Cash 96.07%
Stock 2.26%
Bond 2.43%
Convertible 0.00%
Preferred 0.00%
Other -0.77%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 17.85%    % Emerging Markets: 0.00%    % Unidentified Markets: 82.15%

Americas 8.67%
8.64%
Canada 1.41%
United States 7.23%
0.02%
As of August 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 6.89%
United Kingdom 0.86%
5.86%
Finland 0.05%
France 0.34%
Germany 0.16%
Ireland 2.58%
Netherlands 1.29%
Norway 0.24%
Spain 0.18%
Sweden 0.65%
Switzerland 0.06%
0.00%
0.17%
United Arab Emirates 0.17%
Greater Asia 2.30%
Japan 0.06%
1.20%
Australia 1.06%
1.04%
Singapore 0.84%
Taiwan 0.20%
0.00%
Unidentified Region 82.15%

Bond Credit Quality Exposure

AAA 2.22%
AA 8.06%
A 0.43%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 89.29%
Short Term 0.00%
As of August 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
4.39%
Materials
-0.23%
Consumer Discretionary
-6.48%
Financials
10.94%
Real Estate
0.15%
Sensitive
3.62%
Communication Services
9.99%
Energy
3.24%
Industrials
-5.34%
Information Technology
-4.26%
Defensive
-0.47%
Consumer Staples
-5.15%
Health Care
2.57%
Utilities
2.10%
Not Classified
1.17%
Non Classified Equity
1.17%
As of August 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of August 31, 2026
Type % Net
Government 88.65%
Corporate 0.00%
Securitized 0.75%
Municipal 10.60%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
88.65%
Less than 1 Year
88.65%
Intermediate
1.65%
1 to 3 Years
1.35%
3 to 5 Years
0.00%
5 to 10 Years
0.30%
Long Term
9.69%
10 to 20 Years
0.00%
20 to 30 Years
9.69%
Over 30 Years
0.00%
Other
0.00%
As of August 31, 2026
View Bond Maturity Exposure
Start Trial